Tencent Holdings Limited于2026年8月17日以每股均价32.3366港元买入礼邦医药-B股份3.10万股,涉资约100.24万港元。
Tencent Holdings Limited此次增持前持有礼邦医药-B好仓2353.56万股,占比9.99%;增持后持股量为2356.66万股,好仓比例升至10.0%。
Tencent Holdings Limited于2026年8月17日以每股均价32.3366港元买入礼邦医药-B股份3.10万股,涉资约100.24万港元。
Tencent Holdings Limited此次增持前持有礼邦医药-B好仓2353.56万股,占比9.99%;增持后持股量为2356.66万股,好仓比例升至10.0%。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.